CR10532A - Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage- a3- marker - Google Patents

Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage- a3- marker

Info

Publication number
CR10532A
CR10532A CR10532A CR10532A CR10532A CR 10532 A CR10532 A CR 10532A CR 10532 A CR10532 A CR 10532A CR 10532 A CR10532 A CR 10532A CR 10532 A CR10532 A CR 10532A
Authority
CR
Costa Rica
Prior art keywords
detection
mage
probes
marker
diagnosis
Prior art date
Application number
CR10532A
Other languages
English (en)
Inventor
Thierry Coche
Olivier Gruselle
Craig Lawrence Stephens
Gabriele Anne-Marie Beer
Dennis Salonga
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of CR10532A publication Critical patent/CR10532A/es

Links

CR10532A 2006-06-21 2008-12-18 Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage- a3- marker CR10532A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12342606A 2006-06-21 2006-06-21

Publications (1)

Publication Number Publication Date
CR10532A true CR10532A (es) 2009-01-27

Family

ID=44839439

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10532A CR10532A (es) 2006-06-21 2008-12-18 Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage- a3- marker

Country Status (1)

Country Link
CR (1) CR10532A (es)

Similar Documents

Publication Publication Date Title
IL223604B (en) System for detection of an analyte in a body fluid
EP2370813A4 (en) MATERIALS AND METHODS FOR DIAGNOSIS AND PRESENTATION OF PROSTATE CANCER
EP2250287A4 (en) PROOF AND FORECAST OF LUNG CANCER
EP2306899A4 (en) Detection of hypokinetic and/or hyperkinetic states
BRPI0719202A2 (pt) Diagnóstico e tratamento de câncer usando anticorpo antiereg
EP1896842A4 (en) Non-destructive testing of pipes
EP2021491A4 (en) PROOF OF TUMOR BIOMARKERS IN ORAL CANCER
EP2179037A4 (en) DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES
BRPI0907272A2 (pt) "método de avaliação e aparelho de avaliação de perfusão de vasos perfurantes"
DK2029220T3 (da) Medicinsk sonde
FI20075124A0 (fi) Menetelmä ja testikitti nukleotidivariaatioiden toteamiseksi
EP2210101A4 (en) METHODS AND DEVICE FOR DETECTING OCCULT BLOOD
DE602007009990D1 (de) Sehachsenrichtungs-nachweisvorrichtung und sehlinienrichtungs-nachweisverfahren
BRPI0715346A2 (pt) Detecção de analitos e ácidos nucléicos
GB0711359D0 (en) Systems and methods for identification of clinical study candidates
IL218021A0 (en) Methods, primers, probes and kits useful for the detection of braf mutations
EP2032022A4 (en) DEVICE AND METHOD FOR DETECTING LOCALLY WEIGHTED TISSUE MIXTURE
WO2008073899A3 (en) Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
EP2041569A4 (en) ASSAY FOR DIAGNOSIS OF LUNG CANCER
BRPI0818741A2 (pt) equipamento e método de avaliação da presença de microorganismos no sangue
BRPI0718850A2 (pt) Métodos de tratar, diagnosticar ou detectar câncer
EP2265950A4 (en) PROOF OF BIOMARKERS AND BIOMARKER COMPLEXES
EP2147309A4 (en) METHOD FOR DETECTING PREECLAMPSIA
IL216369B (en) Alpha-difluoromethylornithine for carcinoma diagnosis and treatment of patients with odc1 genotype
ZA200808669B (en) Methods of treating, diagnosing or detecting cancer

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)